Breaking Zelenskyy Seeks Trump’s Help With Musk for Starlink Use in Russia Turkish Man Arrested in UK on U.S. Charges Related to Hamas Funding Allegations FCC Chairman Defends Agency Actions Amidst ABC Dispute Migrant Influx Swells Spanish Enclave to Near-Capacity Big Ten Conference Counters ‘Top-Heavy’ Narrative with Championship Claims

Friday July 31, 2026

Reporter

Nuvectis Pharma, Inc.

2Articles Published

5Communities Covered

Published Articles

Press Release

Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Jul 23

Press Release

Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Jul 23